Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email admin@investorvillage.com

CALA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2750 of 2780  at  1/18/2020 2:32:04 PM  by

wilderguide


 In response to msg 2747 by  JoeFlow
view thread

Re: Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance

"...there may be CANTATA news..."
With 445 recruited across a broad international representation, I feel relatively confident that solid topline CANTATA reporting will provide enough of a dataset to file the NDA. A concurrent P3 might be required, but - given the relatively mild AE profile of CB-839...along with an increased willingness of FDA to approve new options in the space - I'd expect to see such a filing by years' end. If Susan can wait for the data, I don't think she'll have an issue with financing, and might even find PDUFA funding without taking it public. Compelling data might entice MMM to consider a creative partnership within the Cabo franchise.He's overdue the acquisition of an asset, and a deal with CALA could be just the trick for all concerned. Fingers crossed, but I've had good vibes wrt the future of CB-839.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 210
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2751 Re: Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance JoeFlow 5 1/18/2020 6:48:48 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...